One Pulmonary Lesion, 2 Synchronous Malignancies

Introduction. Mantle cell lymphoma (MCL) comprises approximately 3% to 10% of all non-Hodgkin lymphomas. Although there is an increased risk for secondary malignancies after treatment among non-Hodgkin lymphomas survivors, a synchronous diagnosis of primary lung cancer arising in conjunction with ly...

Descripción completa

Detalles Bibliográficos
Autores principales: Aqeel, Masooma, Uysal-Biggs, Nevin, Fenske, Timothy S., Rao, Nagarjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6062774/
https://www.ncbi.nlm.nih.gov/pubmed/30083559
http://dx.doi.org/10.1177/2324709618785934

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6062774/
https://www.ncbi.nlm.nih.gov/pubmed/30083559
http://dx.doi.org/10.1177/2324709618785934

Ejemplares similares